The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...
U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...
Novavax's fourth-quarter loss narrowed on Thursday, helped by reduced selling and administrative expenses of COVID-19 ...
US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...
US health officials are reviewing a nearly $600 million contract awarded to Moderna for bird flu vaccines in the final days ...
HHS review of a vaccine contract sparks worries about preparedness for a potential bird flu pandemic
HHS is re-evaluating a nearly $600 million contract with Moderna to develop and test vaccines against flu viruses that could ...
The funding review is part of a broader government push to examine spending on messenger RNA-based vaccines, the technology that Moderna and Pfizer used to develop their COVID-19 vaccines.
The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results